ClinicalTrials.Veeva

Menu

Questionnaire and Laboratory Data on Vitiligo Vulgaris

S

St. Luke's-Roosevelt Hospital Center

Status

Completed

Conditions

Vitiligo Vulgaris

Study type

Observational

Funder types

Other

Identifiers

NCT01206374
10-027SLRHC

Details and patient eligibility

About

Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.

Full description

Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.

Enrollment

57 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of Vitiligo Vulgaris
  • Ability to sign consent

Exclusion criteria

  • Pregnant
  • Inability to sign consent
  • Inability to complete questionnaire

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems